Evaluation of a new transcutaneous bilirubinometer.

OBJECTIVE The objective of this study was to evaluate the Minolta/Hill-Rom Air-Shields Transcutaneous Jaundice Meter model JM-103. METHODS We studied a convenience sample of 849 newborns > or =35 weeks of gestation in 3 hospitals. These infants had total serum bilirubin (TSB) levels measured on clinical indication, and transcutaneous bilirubin (TcB) levels were obtained within 1 hour of the TSB levels. The population was 59.2% white, 29.8% black, 4.5% East Asian, 3.8% Middle Eastern, 1.6% Indian/Pakistani, and 1.1% Hispanic. RESULTS There was a close correlation between TSB and TcB values in all of the population groups: white (n = 503, r =.949); black (n = 253, r =.822); and East Asian, Indian/Pakistani, and Hispanic (n = 93, r =.926). In the black population, the correlation was less close than in the other groups, and differences between the TcB and TSB measurements tended to increase with rising TSB values. JM-103 values differed from TSB values by 3 mg/dL or more in 2% of white, 3.2% of other, and 17.4% of black infants. In these black infants, the JM-103 value was always greater than the TSB value. CONCLUSIONS We conclude that TcB measurements using the JM-103 jaundice meter correlate very closely with TSB levels over the range of TSB encountered in this study. Because only 3.3% of our infants had TSB values >15 mg/dL (257 micro mol/L), more data are needed in this range of TSB concentration. The correlation in black infants is not as close as in other groups, but because the tendency in blacks is for the JM-103 to overestimate serum bilirubin levels, dangerous clinical errors are unlikely to occur. The measurement technique is rapid and simple, and it is easy to perform repeated measurements over time, thus reducing the likelihood of error. TcB measurements with the JM-103 jaundice meter should obviate the need for most serum bilirubin levels in newborn infants > or =35 weeks of gestation, although serum bilirubin measurements are still required when treatment with phototherapy or exchange transfusion is being considered.

[1]  Francesc Botet,et al.  Prediction of hyperbilirubinaemia in the healthy term newborn , 2001, Acta paediatrica.

[2]  K. Isobe,et al.  New transcutaneous jaundice device with two optical paths , 2003, Journal of perinatal medicine.

[3]  Aap Subcommittee on Neonatal Hyperbilirubinemia.  Neonatal jaundice and kernicterus. , 2001, Pediatrics.

[4]  M. Serdar,et al.  The Value of First-Day Bilirubin Measurement in Predicting the Development of Significant Hyperbilirubinemia in Healthy Term Newborns , 2000, Pediatrics.

[5]  A. Fanaroff,et al.  Prediction of Hyperbilirubinemia in Near-Term and Term Infants , 2001, Journal of Perinatology.

[6]  P. Vos,et al.  Improved Transcutaneous Bilirubinometry: Comparison of SpectR X BiliCheck and Minolta Jaundice Meter JM-102 for Estimating Total Serum Bilirubin in a Normal Newborn Population , 2002, Journal of Perinatology.

[7]  J. Tyson,et al.  Interlaboratory variability of bilirubin measurements. , 1996, Clinical chemistry.

[8]  M. J. Maisels,et al.  Normal serum bilirubin levels in the newborn and the effect of breast-feeding. , 1986, Pediatrics.

[9]  G. Escobar,et al.  Prediction and prevention of extreme neonatal hyperbilirubinemia in a mature health maintenance organization. , 2000, Archives of pediatrics & adolescent medicine.

[10]  K. Fung,et al.  Epidemiology of neonatal hyperbilirubinemia. , 1985, Pediatrics.

[11]  K. Merritt,et al.  HYPERBILIRUBINEMIA IN THE NEWBORN , 1941 .

[12]  J M Bland,et al.  Statistical methods for assessing agreement between two methods of clinical measurement , 1986 .

[13]  V. Bhutani,et al.  System-based approach to management of neonatal jaundice and prevention of kernicterus. , 2002, The Journal of pediatrics.

[14]  W. Frawley,et al.  Assessment of a transcutaneous device in the evaluation of neonatal hyperbilirubinemia in a primarily Hispanic population. , 2002, Pediatrics.

[15]  B. Rosner,et al.  Epidemiology of neonatal hyperbilirubinemia. , 1985, Pediatrics.

[16]  M. J. Maisels,et al.  Transcutaneous bilirubinometry decreases the need for serum bilirubin measurements and saves money. , 1997, Pediatrics.

[17]  I. Holzman,et al.  Noninvasive estimation of serum bilirubin. , 1998, Pediatrics.

[18]  A. Spitzer,et al.  Accuracy of Clinical Judgment in Neonatal Jaundice , 2001 .

[19]  V. Bhutani,et al.  Predictive Ability of a Predischarge Hour-specific Serum Bilirubin for Subsequent Significant Hyperbilirubinemia in Healthy Term and Near-term Newborns , 1999, Pediatrics.

[20]  Vinod K. Bhutani,et al.  Noninvasive Measurement of Total Serum Bilirubin in a Multiracial Predischarge Newborn Population to Assess the Risk of Severe Hyperbilirubinemia , 2000, Pediatrics.

[21]  G. Gourley,et al.  Transcutaneous bilirubin measurement: a multicenter evaluation of a new device. , 2001, Pediatrics.

[22]  K. L. Tan,et al.  Transcutaneous bilirubinometry during and after phototherapy , 2003, Acta paediatrica.

[23]  C. Wong,et al.  A comparison of transcutaneous bilirubinometers: SpectRx BiliCheck versus Minolta AirShields , 2002, Archives of disease in childhood. Fetal and neonatal edition.

[24]  M. J. Maisels,et al.  Length of stay, jaundice, and hospital readmission. , 1998, Pediatrics.

[25]  R. Schumacher.  Noninvasive measurements of bilirubin in the newborn. , 1990, Clinics in perinatology.

[26]  Transcutaneous bilirubin measurements in full-term infants. , 1982, Pediatrics.

[27]  T. Hegyi,et al.  Transcutaneous bilirubinometry. I. Correlations in term infants. , 1981, The Journal of pediatrics.

[28]  M. J. Maisels,et al.  Jaundice in full-term and near-term babies who leave the hospital within 36 hours. The pediatrician's nemesis. , 1998, Clinics in perinatology.

[29]  Edwin L. Bradley,et al.  Comparing Paired Data: A Simultaneous Test for Means and Variances , 1989 .

[30]  D. Stevenson,et al.  Laboratory evaluation of jaundice in newborns. Frequency, cost, and yield. , 1990, A M A Journal of Diseases of Children.

[31]  C. Hammerman,et al.  Predischarge Bilirubin Screening in Glucose-6-Phosphate Dehydrogenase-Deficient Neonates , 2000, Pediatrics.

[32]  D. Stevenson,et al.  Reduction in hospital readmission rates for hyperbilirubinemia is associated with use of transcutaneous bilirubin measurements. , 2005, Clinical chemistry.

[33]  A. Fanaroff,et al.  Prediction of hyperbilirubinemia in near-term and term infants. , 2001, Journal of perinatology : official journal of the California Perinatal Association.

[34]  L. Rasmussen,et al.  A new transcutaneous bilirubinometer, BiliCheck, used in the neonatal intensive care unit and the maternity ward , 2002, Acta paediatrica.

[35]  M. J. Maisels,et al.  Kernicterus in otherwise healthy, breast-fed term newborns. , 1995, Pediatrics.

[36]  L Briscoe,et al.  Can transcutaneous bilirubinometry reduce the need for blood tests in jaundiced full term babies? , 2002, Archives of disease in childhood. Fetal and neonatal edition.